Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease-Reference-Cited by-同舟云学术

Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease

Author:

Hopewell J. C.¹,Seedorf U.²,Farrall M.³⁴,Parish S.¹,Kyriakou T.³⁴,Goel A.³⁴,Hamsten A.⁵,Collins R.¹,Watkins H.³⁴,Clarke R.¹,

Affiliation:

1. Clinical Trial Service Unit and Epidemiological Studies Unit; Nuffield Department of Population Health; University of Oxford; Oxford UK

2. Leibniz-Institut für Arterioskleroseforschung an der Universität Münster; Münster Germany

3. Division of Cardiovascular Medicine; Radcliffe Department of Medicine; University of Oxford; Oxford UK

4. The Wellcome Trust Centre for Human Genetics; University of Oxford; Oxford UK

5. Atherosclerosis Research Unit; Department of Medicine; Karolinska Institutet; Stockholm Sweden

Funder

British Heart Foundation

AstraZeneca

Wellcome Trust

UK Medical Research Council

Swedish Heart-Lung Foundation

Swedish Medical Research Council

Knut and Alice Wallenberg Foundation

Karolinska Institutet

Publisher

Wiley

Subject

Internal Medicine

Link

Reference29 articles.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献